Skip to main content

Part of the book series: Practical Case Studies in Hypertension Management ((PCSHM))

  • 812 Accesses

Abstract

A 42-year-old, Caucasian female was referred by her endocrinologist to confirm the diagnosis of arterial hypertension, since in the last visits, she has presented high blood pressure (BP). She was not on antihypertensive drugs. 24-h ambulatory BP monitoring (ABPM) was performed, and the final diagnosis was ‘white-coat hypertension’, also called ‘isolated clinic hypertension’.

Definition of ‘white-coat hypertension’ includes untreated patients with elevated office BP and normal 24-h ABPM. White-coat hypertension is not a benign condition, being potentially related to higher mean BP levels over 24 h compared to normotensive individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA. 1988;259:225–8.

    Google Scholar 

  2. Banegas JR, Ruilope LM, Williams B. White-coat uncontrolled hypertension, masked uncontrolled hypertension and true uncontrolled hypertension, phonetic and mnemonic terms for treated hypertension phenotypes. J Hypertens. 2018;36:446–7.

    Google Scholar 

  3. Vinyoles E, Rodriguez-Blanco T, de la Sierra A, Felip A, Banegas JR, de la Cruz JJ, et al., on behalf of the Spanish Society of Hypertension ABPM Registry Investigators. Isolated clinic hypertension: diagnostic criteria based on 24-h blood pressure definition. J Hypertens. 2010;28:2407–13.

    Google Scholar 

  4. O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al., on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension Position Paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–68.

    Google Scholar 

  5. Myers MG, Valdivieso M, Kiss A. Use of automated office blood pressure measurement to reduce the white coat response. J Hypertens. 2009;27:280–6.

    Google Scholar 

  6. Williams B, Mancia G, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. J Hypertens. 2018;39(33):3021–104.

    Google Scholar 

  7. Vinyoles E, Felip A, Pujol E, de la Sierra A, Durà R, del Rey RH, et al., on behalf of the Spanish Society of Hypertension ABPM Registry. Clinical characteristics of isolated clinic hypertension. J Hypertens. 2008;26:438–54.

    Google Scholar 

  8. Tocci G, Presta V, Figliuzzi I, Attalla El Halabieh N, Battistoni A, Coluccia R, et al. Prevalence and clinical outcomes of white-coat and masked hypertension: analysis of a large ambulatory blood pressure database. J Clin Hypertens. 2018;20:297–305.

    Google Scholar 

  9. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25:2193–8.

    Google Scholar 

  10. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011;24:52–8.

    Google Scholar 

  11. Franklin SS, Thijs L, Asayama K, Li Y, Hansen TW, Boggia J, et al. The cardiovascular risk of white-coat hypertension. J Am Coll Cardiol. 2016;68:2033–43.

    Google Scholar 

  12. Ugajin T, Hozawa A, Ohkubo T, Asayama K, Kikuya M, Obara T, et al. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch Intern Med. 2005;165:1541–6.

    Google Scholar 

  13. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005;45:203–8.

    Google Scholar 

  14. Briasoulis A, Androulakis E, Palla M, Papageorgiou N, Tousoulis D. White-coat hypertension and cardiovascular events: a meta-analysis. J Hypertens. 2016;34:593–9.

    Google Scholar 

  15. Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, et al. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension. 2014;63:675–82.

    Google Scholar 

  16. Huang Y, Huang W, Mai W, Cal X, An D, Liu Z, et al. White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J Hypertens. 2017;35:677–88.

    Google Scholar 

  17. Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Engl J Med. 2018;378:1509–20.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Segura, J. (2019). Patient with White-Coat Hypertension. In: Hypertension and 24-hour Ambulatory Blood Pressure Monitoring. Practical Case Studies in Hypertension Management. Springer, Cham. https://doi.org/10.1007/978-3-030-02741-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-02741-4_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-02740-7

  • Online ISBN: 978-3-030-02741-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics